Symbol="BTAI"
AssetType="Common Stock"
Name="BioXcel Therapeutics Inc"
Description="BioXcel Therapeutics, Inc., a clinical-phase biopharmaceutical company, focuses on the development of artificial intelligence-based drugs in the fields of neuroscience and immuno-oncology in the United States. The company is headquartered in New Haven, Connecticut."
CIK="1720893"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="555 LONG WHARF DRIVE, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="215781000"
EBITDA="-179032992"
PERatio="None"
PEGRatio="None"
BookValue="1.821"
DividendPerShare="0"
DividendYield="0"
EPS="-6.12"
RevenuePerShareTTM="0.021"
ProfitMargin="0"
OperatingMarginTTM="-308.71"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-1.515"
RevenueTTM="581000"
GrossProfitTTM="355000"
DilutedEPSTTM="-6.12"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="47.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4131.89"
PriceToBookRatio="3.966"
EVToRevenue="2657.94"
EVToEBITDA="-2.748"
Beta="0.878"
num_52WeekHigh="34.12"
num_52WeekLow="3.815"
num_50DayMovingAverage="13.22"
num_200DayMovingAverage="19.99"
SharesOutstanding="29159600"
DividendDate="None"
ExDividendDate="None"
symbol="BTAI"
open="4.98"
high="5.02"
low="3.81"
price="4.33"
volume="9761081.00"
latest_trading_day="2023-08-14"
previous_close="7.40"
change="-3.07"
change_percent="-41.4865%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="82"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="1967922"
Change_recent_avg="-0.06"
Delta_recent_avg="1.38"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="-0.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0012.jpeg"
image_negative_thumbnail_id_2="517"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_neutral_thumbnail_id_1="582"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="616"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_positive_thumbnail_id_2="674"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
